ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-9 |

Results: 9

EAU guidelines on prostate cancer

Authors: Aus, G Abbou, CC Pacik, D Schmid, HP van Poppel, H Wolff, JM Zattoni, F

Citation: G. Aus et al., EAU guidelines on prostate cancer, EUR UROL, 40(2), 2001, pp. 97-101

Aims and methods

Authors: Prezioso, D Scarpa, RM Zattoni, F Viaggi, S Termini, R Berioli, S Rizzi, CA

Citation: D. Prezioso et al., Aims and methods, EUR UROL, 40, 2001, pp. 2-4

Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study

Authors: Bono, AV Pagano, F Montironi, R Zattoni, F Manganelli, A Selvaggi, FP Comeri, G Fiaccavento, G Guazzieri, S Selli, C Lembo, A Cosciani-Cunico, S Potenzoni, D Muto, G Diamanti, L Santinelli, A Mazzucchelli, R Prayer-Galletti, T

Citation: Av. Bono et al., Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study, UROLOGY, 57(1), 2001, pp. 117-121

Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers

Authors: Messa, P Londero, D Massarino, F Paganin, L Mioni, G Zattoni, F Cannella, G

Citation: P. Messa et al., Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers, NEPH DIAL T, 15(9), 2000, pp. 1388-1393

Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenario

Authors: Gion, M Mione, R Barioli, P Barichello, M Zattoni, F Prayer-Galetti, T Plebani, M Aimo, G Terrone, C Manferrari, F Madeddu, G Caberlotto, L Fandella, A Pianon, C Vianello, L Amoroso, B

Citation: M. Gion et al., Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenario, EUR UROL, 37(4), 2000, pp. 460-469

Immediate or deferred hormone ablation in PSA relapse after radical prostatectomy

Authors: Zattoni, F Valotto, C Bierti, S

Citation: F. Zattoni et al., Immediate or deferred hormone ablation in PSA relapse after radical prostatectomy, PROSTATE C, 2, 1999, pp. S5-S7

Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer - Initial results of the Italian PROSIT study

Authors: Montironi, R Diamanti, L Santinelli, A Galetti-Prayer, T Zattoni, F Selvaggi, FP Pagano, F Bono, AV

Citation: R. Montironi et al., Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer - Initial results of the Italian PROSIT study, PATH RES PR, 195(4), 1999, pp. 201-208

Neoadjuvant hormone therapy before surgery for prostate cancer: The Italian Experience (PROSIT Study)

Authors: Pagano, F Bono, A Zattoni, F Montironi, R Galetti, TP

Citation: F. Pagano et al., Neoadjuvant hormone therapy before surgery for prostate cancer: The Italian Experience (PROSIT Study), MOL UROL, 2(3), 1998, pp. 189-194

Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions

Authors: Gion, M Mione, R Barioli, P Barichello, M Zattoni, F Prayer-Galetti, T Plebani, M Aimo, G Terrone, C Manferrari, F Madeddu, G Caberlotto, L Fandella, A Pianon, C Vianello, L

Citation: M. Gion et al., Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions, CLIN CHEM, 44(12), 1998, pp. 2462-2470

Risultati: 1-9 |